Cargando…
Understanding p53 tumour suppressor network
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulation of several cellular functions, including cell cycle progression and cell death in response to genotoxic stress. In the recent years additional p53-mediated tumour suppression mechanisms have been d...
Autores principales: | Panatta, Emanuele, Zampieri, Carlotta, Melino, Gerry, Amelio, Ivano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348811/ https://www.ncbi.nlm.nih.gov/pubmed/34362419 http://dx.doi.org/10.1186/s13062-021-00298-3 |
Ejemplares similares
-
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
por: Mammarella, Eleonora, et al.
Publicado: (2021) -
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer
por: Zampieri, Carlotta, et al.
Publicado: (2022) -
p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer
por: Butera, Alessio, et al.
Publicado: (2022) -
p53 regulates expression of nuclear envelope components in cancer cells
por: Panatta, Emanuele, et al.
Publicado: (2022) -
Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)